Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DB25FHZ58
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,781
Award facts
- Contract value 100% obligated
- $14,780.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of HUMIRA (Adalimumab) CF Pen 40 mg/0.4 mL, a biologic medication used to treat inflammatory conditions. This competitively awarded, firm fixed-price delivery order has a ceiling value of $14,780.85 and an ultimate completion date of July 22, 2025. The contract is not set-aside and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical commodities globally to military healthcare programs.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor. The company fulfills extensive pharmaceutical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its DLA prime vendor contract, which covers a comprehensive range of products including specialty medications, branded and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order reflects the company's ongoing role as a primary supplier within the DLA Medical Supply Chain's pharmacy and medical support operations.
Quick answers
Who was awarded contract SPE2DB25FHZ58?
SPE2DB25FHZ58 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FHZ58 worth?
The government has obligated $14,781 on SPE2DB25FHZ58.
Is contract SPE2DB25FHZ58 an order under another contract?
Yes. SPE2DB25FHZ58 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FHZ58 competed?
The extent of competition for SPE2DB25FHZ58 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award